Arrowhead Pharmaceuticals
ARWR
#2099
Rank
A$13.51 B
Marketcap
A$97.73
Share price
-0.64%
Change (1 day)
172.03%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: A$13.51 Billion

As of December 2025 Arrowhead Pharmaceuticals has a market cap of A$13.51 Billion. This makes Arrowhead Pharmaceuticals the world's 2099th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025A$13.51 B256.22%
2024A$3.79 B-21.39%
2023A$4.82 B-28.87%
2022A$6.78 B-29.03%
2021A$9.55 B-6.78%
2020A$10.25 B11.94%
2019A$9.16 B461.16%
2018A$1.63 B362.81%
2017A$0.35 B121.15%
2016A$0.15 B-68.32%
2015A$0.50 B2.02%
2014A$0.49 B4%
2013A$0.47 B1372.64%
2012A$32.21 M-25.1%
2011A$43.01 M-32.01%
2010A$63.26 M70.79%
2009A$37.04 M-33.83%
2008A$55.98 M-66.55%
2007A$0.16 B-12%
2006A$0.19 B-2.47%
2005A$0.19 B147.51%
2004A$78.79 M55352.54%
2003A$0.14 M152.95%
2002A$0.05 M-63.77%
2001A$0.15 M-72.94%
2000A$0.57 M50.11%
1999A$0.38 M-11.28%
1998A$0.43 M75.51%
1997A$0.24 M

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Arrowhead Pharmaceuticals was reported to be:

A$13.27 Billion
by Nasdaq info icon info icon
A$13.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
A$92.91 B 587.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.50 B-66.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$5.60 B-58.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$0.20 B-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$737.31 B 5,356.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$15.05 B 11.41%๐Ÿ‡บ๐Ÿ‡ธ USA